Scientific Representative of The Michael J. Fox Foundation for Parkinson’s Research.

Brian K. Fiske, PhD, is Vice President of Research Programs at The Michael J. Fox Foundation for Parkinson’s Research. In this role, he manages a team of research professionals who stay closely linked to the Parkinson’s research community in order to develop an aggressive and innovative agenda for accelerating research and drug development for Parkinson’s disease.
Dr. Fiske earned a Bachelor of Science degree in cellular and molecular biology from Texas A&M University and a Ph.D. in neuroscience from the University of Virginia. After completing postdoctoral research at Columbia University in New York, Brian spent several years as a science editor at the journal Nature Neuroscience. He joined the scientific staff of The Michael J. Fox Foundation for Parkinson’s Research in 2004.

Main publications:

1. Ross, O. A., et al. “Association of LRRK2 exonic variants with susceptibility to Parkinson’s disease: a case-control study.” Lancet Neurol. (2011).
2. Dorsey, E. R., et al. “Funding of Parkinson research from industry and US federal and foundation sources.” Mov Disord. 24.5 (2009): 731-37.
3. Fiske, B. K., M. A. Frasier, and T. B. Sherer. “Special focus section: gene therapy for Parkinson’s disease.” Exp.Neurol. 209.1 (2008): 28-29.
4. Elbaz, A., et al. “Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson’s disease: a large-scale international study.” Lancet Neurol. 5.11 (2006): 917-23.
5. Sherer, T. B., et al. “Crossroads in GDNF therapy for Parkinson’s disease.” Mov Disord. 21.2 (2006): 136-41.